Skip to main content
. Author manuscript; available in PMC: 2014 Jan 31.
Published in final edited form as: Science. 1988 Jul 8;241(4862):213–215. doi: 10.1126/science.2838906

Table 1.

Serological characterization of the W1/2–1D-1 hybrid virus with neutralizing polyclonal antibodies. TCID50, median tissue culture infectious dose.

Virus Dilution of antibody neutralizing 100 TCID50
Antibody to
Type 1 Type 2
PV-1(M) >1:4096 <1:2
PV-2(L) <1:2 1:2048
W1/2–1D-1 >1:4096 1:64